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1.  Introduc+on  
 Apolipoprotein B mRNA‐edi+ng cataly+c polypep+de (APOBEC) deaminases are a family of 
proteins, which include AID, APOBEC1, 2, 3A, 3B, 3C, 3DE, 3F, 3G, 3H, and 4 [1e4]. APOBEC3 
(A3) proteins are an+viral factors that inhibit viruses and transposable elements, both of 
which use reverse transcrip+on during their life cycle [1e4]. The an+viral func+ons of A3 
proteins have been extensively studied in human immunodeﬁciency virus 1 (HIV‐1) and 
hepa++s B virus (HBV) infec+ons. In the case of HIV‐1, A3G‐induced hypermuta+on of viral 
DNA inhibits HIV‐1 replica+on either by base excision repair (BER)‐mediated DNA cleavage or 
accumula+on of destruc+ve mu‐ ta+ons in the viral genome [1e4]. Furthermore, deaminase‐ 
independent an+viral ac+vi+es are reported; A3G is proposed to block elonga+on of HIV‐1 
and HBV DNA by reverse transcrip+on through a deaminase‐independent mechanism [5,6]. 
In addi+on, binding of A3G with viral RNA is proposed to be important for inhibi+ng reverse 
transcrip+on of retroviral genomes [7]. Human papillomaviruses (HPVs) are small double‐
stranded DNA viruses, and a subset of HPVs are recognized as causa+ve agents of anogenital 
and oropharyngeal cancers [8e10], where HPV16 accounts for at least 50% of cervical cancer 
cases worldwide [11]. The HPV16 genome is a 7.9‐kb closed circular DNA comprising at least 
eight open reading frames (ORFs) (E1, E2, E4, E5, E6, E7, L1, and L2) and a noncoding long 
control region (LCR). The LCR con‐ tains viral replica+on origin and an early promoter 
responsible for transcrip+on of E6 and E7 oncogenes required for cellular trans‐ forma+on, 
while L1 and L2 encode the viral capsid proteins [8,9,11]. HPV16 infects the basal cell in 
cervical epithelia and establishes its genome as extrachromosomal episomes. Viral 
replica+on and capsid expression are induced in synchrony with host cell diﬀer‐ en+a+on, 
and virions are assembled in the upper layer of epithelia and released into cell surroundings  
once the host cell is exofoliated aaer terminal diﬀeren+a+on [9]. We have recently demonstrated 
that the HPV16 E2 gene is hypermutated by endogenous A3A and A3G induced by interferon b 
(IFN‐b) in W12 cells [12], human cervical kera+nocytes derived from a CIN1 biopsy that maintains 
HPV16 episomes [13]. Despite the observed hypermuta+on, the levels of HPV16 episomal ge‐ 
nomes were not aﬀected under the condi+on of A3s up‐regula+on. Thus, the pathophysiological 
relevance of A3 proteins in HPV infec+on remains unknown. To examine the an+viral role for A3 
proteins, par+cularly in the virion assembly, we u+lized an HPV16 pseudovirion (PsV) system [14]. 
Our results suggest that A3A and A3C exert their an+viral ac+vi+es during the assembly phase of 
the HPV16 virion.  
2. Material and methods  
2.1. Cell culture 293FT cells were purchased from Life Technologies and main‐ tained in DMEM 
(10% FBS, 0.1 mM Non‐Essen+al Amino Acids, 6 mM L‐glutamine, 1 mM Sodium Pyruvate, and 
Penicillin/Strep‐ tomycin), as instructed by the supplier. HeLa cells were maintained in DMEM (10% 
FBS, Penicillin/Streptomycin).  
2.2. Plasmid construc+on  
To create pEF‐nLuc, the NanoLuc coding sequence from the pNL1.1 vector (Promega, N1001) was 
subcloned into the pEF‐BOS‐ EX vector [15]. pHPV16‐L1/L2 was previously described [16]. FLAG‐
tagged green ﬂuorescent protein (GFP), A3A (Acc. No. XM_005261387), A3F (Acc No. NM_145298) 
and A3G (Acc No. NM_021822) expression vectors were previously described [12,17]. For the 
FLAG‐A3C expression vector, an ORF of human A3C (NM_014508) was ampliﬁed by RT‐PCR with 
forward (50 ‐AAA‐ GAATTCATGAATCCACAGATCAGAA‐30 ) and reverse (50 ‐AAAACTC‐ 
GAGTCACTGGAGACTCCCGTAG‐30 ) primers using cDNA derived from HepG2 cells. The fragment 
was then cloned into pCMV3TAG1A (Invitrogen). For the FLAG‐A3H expression vector, an ORF of 
human A3H (FJ376616) was ampliﬁed by RT‐PCR with for‐ ward (50 ‐ 
AAAGAATTCATGGCTCTGTTAACAGCCGAA‐30 ) and reverse (50 ‐
AATAGTCGACTCAGACCTCAGCATCACACA‐30 ) primers using cDNA derived from CaSki (human 
kera+nocyte cell line) cells. The fragment was subsequently cloned into pCMV3TAG1A. 
Successful construc+on of plasmids was conﬁrmed by DNA sequencing. 
 2.3. PsV prepara+on and infec+vity assay  
We closely followed the protocol provided by Buck et al. [14]. In brief, 293FT cells were 
cotransfected using Lipofectamine 2000 (Life technologies) with pEF‐nLuc, pHPV16‐L1/L2, and 
pFLAG‐A3 proteins, as per the manufacturer's instruc+on. Two days aaer transfec+on, the cells 
were harvested and lysed with phosphate‐ buﬀered saline (PBS) containing 0.5% Triton‐X 100, 1 
mM ATP, 25 mM ammonium sulfate, 1 mg/mL RNase A (Sigma), 50 mg/ml DNase I grade II 
(Roche), and 0.1% Plasmid‐Safe (Epicentre). The lysates were incubated for at least 16 h at 37  C 
to induce matura+on of PsVs, followed by addi+on of sodium chloride at a ﬁnal concentra+on of 
0.85 M. The lysates were incubated on ice for 10 min and centrifuged at 4  C at 5000  g for 5 
min. 2 x 10 4 HeLa cells per well of a 24 well plate were incubated with the superna‐ tant (high 
salt extract, HSE) with a 2000‐fold dilu+on of the culture media, unless noted. Two days later, 
the cells were harvested by trypsin digest, and the luciferase ac+vity was measured using the 
Nano‐Glo Luciferase Assay system (Promega), as per the manufac‐ turer's instruc+on. Challenge 
of HSEs from the GFP control to a well without HeLa cells yielded a luciferase ac+vity of 
~300e400 rela‐ +ve luciferase units (data not shown), comparable to the value of the empty 
wells. Thus, the residual luciferase ac+vity in HSEs was considered to be negligible. In addi+on, 
Buck et al. demonstrated that challenging HSEs allowed 293H cells to express the reporter gene 
in a L1 or L2 dependent manner [18]. Hence, we jus+ﬁed challenging HSE as a method to assess 
infec+vity of PsVs. 2.4. Western blomng Western blomng was performed as previously described 
[12,17]. The an+bodies used in this study were: rabbit an+‐GAPDH (G9545, Sigma), horseradish 
peroxidase (HRP)‐conjugated an+rabbit IgG (GE Healthcare), mouse an+‐FLAG (M2, Sigma), 
mouse an+‐Myc (9E10, sc‐40, Santa‐Cruz), mouse an+‐HPV16 L1 (ab69, Abcam), and an+mouse 
IgGeHRP (GE Healthcare). Signal development was performed using ECL Western Blomng 
Detec+on Reagents (Amer‐ sham) and signal detec+on was achieved using the LAS1000 imager 
system (FujiFilm). 2.5. Copy number determina+on of pEF‐nLuc by qPCR described [12]. To 
prepare nuclease‐resistant DNA, 2 ml of HSEs were added to 10 ml of extrac+on buﬀer (10 mM 
Tris pH 8.0, 150 mM NaCl, 25 mM EDTA, 1% NP‐40, and 200 mg/ml proteinase K) at 50 ! C 
overnight to degrade PsV capsid proteins. The resul+ng extracts were diluted 10‐fold in double‐
dis+lled water, incubated at 95  C for 7 min to heat‐inac+vate proteinase K, and subjected to 
qPCR. For quan+ﬁca+on of the pEF‐nLuc copy number, forward (50 ‐ 
TCCTTGAACAGGGAGGTGTGT‐30 ) and reverse (50 ‐CGATCTTCAGCC‐ CATTTTCAC‐30 ) primers 
were used. Speciﬁcity and linearity of the quan+ﬁca+on were conﬁrmed using pEF‐nLuc as a 
template (data not shown). Copy numbers of pEF‐nLuc in total cell lysates or HSEs were 
determined by qPCR. Serially diluted pEF‐nLuc was used to obtain the standard curve for 
calcula+ng the copy numbers of each sample. 2.6. Immunoprecipita+on Cells were lysed with 
PBS containing 1% Triton‐X 100, 0.5% Tween 20, and a complete protease inhibitor cocktail 
tablet (Roche). Immune complexes were collected using an An+‐FLAG M2 Afﬁnity Gel or an An+‐
c‐Myc Agarose Afﬁnity Gel (Sigma, A2220 and A7470, respec+vely), as per the manufacturer's 
instruc+ons. Precipitated complexes were puriﬁed using Micro Bio‐Spin Chro‐ matography 
Columns (BioRad, #732e6304) and eluted with buﬀer containing 6% SDS, 50 mM TriseHCl, and 
150 mM NaCl. 2.7. Sta+s+cal analysis Sta+s+cal analyses were performed using GraphPad Prism 
(GraphPad Soaware). The two‐tailed unpaired t‐test was used for determining signiﬁcance by 
qPCR and luciferase assay. P values of <0.05 obtained between experimental groups were 
considered sta+s+cally signiﬁcant. In all graphs displayed in this study, error  
bars indicate the standard error of the mean from duplicate or triplicate samples.  
3. Results  
3.1. A3A and A3C reduce infec+vity of HPV16 PsV We previously reported that A3s are 
abundantly expressed in W12 cells, compared to AID or A1 [12]. Furthermore, our RT‐qPCR 
analysis revealed that both HPV16 ( ‐) and (+) cervical +ssues ex‐ press A3s (data not shown). 
These ﬁndings mo+vated us to explore the possibility that A3 proteins inﬂuence the assembly of 
the HPV16 virion by u+lizing the produc+on system of PsV [14]. Each expression vector 
producing A3 proteins or GFP was co‐transfected with an HPV16 capsid expression vector 
(pHPV16‐L1/L2) and a luciferase reporter plasmid (pEF‐nLuc). Two days later, the cell lysates 
containing PsV were prepared under high salt condi+ons. These lysates (called HSEs) were 
further treated with a nuclease to digest DNA not encapsidated into the PsV, while leaving 
encapsi‐ dated reporter plasmids intact. To determine infec+vity, HeLa cells seeded in a well of 
24‐well plate were challenged with 0.25 ml of HSEs prepared from 293FT cells overexpressing 
each A3, and the luciferase ac+vity was determined 48 h aaer infec+on (Fig 1A). As shown in Fig. 
1A, HSEs prepared from A3A, A3C, A3F, and A3G were less infec+ous than that prepared from 
GFP. The reduced infec+vity of PsV in the presence of A3G, A3F and A3H could be partly 
asributed to decreased capsid protein (L1) levels in HSEs of A3 transfected cells compared with 
that of GFP transfected cells (Fig. 1B). It is currently unknown why L1 protein levels decreased in 
A3 transfected cells compared with GFP transfected cells. To compare infec+vity of PsVs 
produced from A3 transfected cells that contained varying amounts of the L1 capsid protein, we  
+trated GFP HSE by 2‐fold serial dilu+on, and determined rela+on between luciferase ac+vity 
and L1 protein levels, by plomng the L1 level against the luciferase ac+vity for both GFP and 
each A3 protein (Fig. 1C). As expected, the amount of L1 protein and luciferase ac‐ +vity 
correlated well across the serially diluted GFP HSE. Plots of A3A, A3C, and A3H were posi+oned 
below the curve of GFP (Fig. 1C). This result indicates that the infec+vity of A3A, A3C, and A3H 
HSEs was lower than the GFP HSE, even aaer normalizing for the amount of L1. A3F and A3G 
plosed to the same line as GFP (Fig. 1C), indica+ng that A3F and A3G reduced L1 protein levels 
but did not reduce the infec+vity of the PsV. A3H expression slightly reduces infec+vity even 
aaer normaliza+on (Fig. 1C right side); however, decrease of L1 protein level was signiﬁcant (Fig. 
1B right side). Therefore, it is not easy to determine whether A3H decreases PsV infec+vity. 
Taken together, we concluded that A3A and A3C asenuate HPV16 PsV infec+vity. 
 3.2. Expression of A3A, but not A3C, aﬀects encapsida+on of PsV DNA We then inves+gated 
how A3A and A3C act to decrease PsV infec+vity. First, total DNA was puriﬁed from the producer 
cells and reporter plasmid levels were determined. As shown in Fig. 2A, the copy numbers of the 
reporter plasmid in total DNA were compa‐ rable between each sample. Because A3A is thought 
to hyper‐ mutate foreign DNA [19], DNA sequencing of the reporter plasmid was performed. A 
reporter gene fragment (560 bp) was ampliﬁed from the total DNA of A3A‐expressing producer 
cells and the fragment was cloned into the pGEM‐T Easy Vector (Promega). This vector was 
transformed into Escherichia coli and 24 clones were randomly selected. DNA sequencing of 
these clones (24 x 560= 13440 bp) revealed an absence of C‐to‐T and G‐to‐A muta+ons (data not 
shown). These results suggest that neither diﬀerences in transfec+on efﬁciency or foreign DNA 
hypermuta+on can explain the reduc+on of infec+vity by A3A (Figs. 1C and 2A). Furthermore, 
we determined reporter plasmid levels in the HSEs. Because HSEs were obtained following 
nuclease diges+on, reporter plasmid levels in HSEs should reﬂect the level of encap‐ 
encap‐ sidated PsV DNA. As expected from the decreased L1 protein levels in the HSEs compared 
to the GFP HSE, all A3 samples exhibited a lower copy number of the reporter plasmid than the 
GFP control (Fig. 2B). To evaluate the copy number of the reporter plasmid per single PsV, copy 
numbers of serially diluted HSE from GFP trans‐ fected cells were determined and plosed along 
with A3 proteins against L1 levels (Fig. 2C). Only A3A exhibited a reduced reporter plasmid copy 
number as measured per L1 level. Other groups compared the infec+vity of PsVs by adjus+ng 
the amount of reporter plasmid [20, 21]. To evaluate infec+vity of A3 HSEs per pseudogenome, 
the same data used in Figs. 1 and 2 were plosed according to the copy number of the reporter 
plasmid. (Supplementary Fig. 1). Infec+vity of A3A and A3C per pseudoge‐ nome was lower than 
that of GFP, however, L1 levels per psuedo‐ genome were higher for A3A HSE and equivalent for 
A3C to that of GFP, while in A3F, A3G, and A3H HSEs, both infec+vity and L1 protein levels per 
pseudogenome were lower than those of GFP (Supplementary Fig. 1, lower). Even aaer 
conduc+ng diﬀerent an‐ alyses, we obtained the same conclusion; the decreased infec+vity of 
HSEs from A3F, A3G, and partly A3H, could be asributed to the decreased L1 expression, while 
A3A reduce infec+vity by reducing pseudogenome per PsV. Taken together, these results 
suggests that A3A interferes with encapsida+on of the reporter plasmid, whereas A3C decreases 
PsV infec+vity by a mechanism other than encapsida+on of the pseudogenome. 
 3.3. Binding of A3 proteins with L1 capsid protein in vitro Because the encapsida+on process 
failed to explain the decreased infec+vity of PsVs in A3C HSE, we next explored whether A3C 
aﬀects PsV infec+vity by interac+ons with the capsid proteins. To this end, we expressed Myc‐
tagged L1 and FLAG‐tagged A3 proteins in 293FT cells. Co‐immunoprecipita+on (IP) experiments 
revealed that FLAG‐A3C, ‐A3F, ‐A3G, and ‐A3H, co‐precipitated Myc‐L1, while almost no GAPDH, 
FLAG‐GFP and negligible FLAG‐ A3A proteins were precipitated with Myc‐L1 (Fig. 3 middle). 
Consistent with this result, IP complexes of Myc‐L1 exhibit detectable levels of FLAG‐A3C, 3F, 3G, 
and 3H, but not GFP and A3A (Fig. 3 bosom). Of note, FLAG‐A3C most efﬁciently pulled down 
Myc‐L1 among these four (Fig. 3 middle). The dis+nguished binding property of A3C for L1 was 
also demonstrated by another co‐IP experiment, using total lysates from 293FT cells transfected 
with pHPV16‐L1/L2, pEF‐nLuc, and FLAG‐A3s, from which we obtained HSEs (Supplementary Fig. 
2). Collec+vely, these data indicate that A3C efﬁciently (while A3F and A3G modestly) binds to 
the L1 capsid protein in vitro. 4. Discussion In this study, we inves+gated the role of APOBEC3 
proteins during the assembly phase of the HPV16 virion. Using the PsV produc+on system, which 
recapitulates the assembly phase of the HPV16 virion, we demonstrated that A3A and A3C 
reduce the PsV infec+vity when co‐expressed in 293FT cells (Fig. 1). The levels of the 
encapsidated pseudogenome were decreased in PsVs prepared from A3A transfected cells, but 
not other A3s transfected cells (Fig. 2). To clarify the mechanism underling the reduced 
infec+vity, we examined whether A3 proteins bind to the HPV16 L1 capsid. A3C efﬁciently bound 
to L1, but A3A did not (Fig. 3, Supplementary Fig. 2), implying that the A3C binding to L1 may 
impair PsV infec‐ +vity. Notably, A3A and A3C localize both in the nucleus and cytoplasm, 
whereas A3F and A3G are distributed to the cytoplasm [22].  
Unexpectedly, co‐transfec+on of pHPV16‐L1/L2 with pFLAG‐A3s resulted in decreased L1 
expression (Fig. 1B, Supplementary Fig. 2, top). Meanwhile, Myc‐L1 was not obviously decreased 
by 
co‐expression with FLAG‐A3s (Fig. 3, top). We do not deny the possibility that A3s are involved in 
the degrada+on of L1 protein or mRNA, which does not target Myc‐tagged L1. We have 
demonstrated that A3C binds to HPV16 L1 in vitro, which implies the mechanism how A3C 
reduces the infec+vity. Binding capacity of L1 with heparan sulfate proteoglycans (HSPGs) is 
proposed to be important for the primary asachment on the cell surface, internaliza+on, and 
uncoa+ng of the capsid, to allow the pseudogenome to enter the nucleus [23]. Therefore, it is 
intriguing to speculate that A3C blocks either of these steps, by binding with L1, to deprive 
HSPGs of its access to the PsVs. During preparing this manuscript, Warren et al. reported that 
A3A could decrease the infec+vity of HPV16 PsV, which is consis‐ tent with this study [21]. 
However, they concluded that A3C does not aﬀect HPV16 PsV infec+vity. In their study, 
recombinant HPV16 genomic DNA with a GFP reporter gene, driven by SV40 promoter, was used 
as a pseudogenome and infec+vity of PsVs prepared from A3C‐expressing cells was determined 
by GFP expression in infected cells. In this study, a vector encoding a luciferase reporter gene 
driven by EF1a promoter was used, therefore, the discrepancy be‐ tween that study and the 
present work can be asributed to the diﬀerences in reporter gene and cell lines used. In 
summary, this study provides for the ﬁrst +me the evidence for the involvement of A3 proteins 
in interference with HPV16 virion assembly. Further studies are required to clarify the speciﬁc 
mechanism of how A3 proteins mediate this infec+vity defect. 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Fig. 1. A3 protein expression decreased infec+vity of HPV16 PsV. (A) 293FT cells were cotransfected with an L1/L2 expression vector (pHPV16‐L1/L2), reporter 
plasmid (pEF‐ nLuc), and an expression vector producing each A3 protein or GFP. Transfected 293FT cells were harvested at 48 h aaer transfec+on and HSE‐
containing PsVs were prepared. 100 ml of HSE was prepared from a well of a 6‐well plate of transfected 293FT cells. 0.25 ml of each HSE (0.25% of the HSE 
frac+on) was used to challenge HeLa cells seeded in a well of a 24‐well plate. Cells were harvested and luciferase ac+vity was determined 48 h post infec+on. 
For control cells transfected with pFLAG‐GFP, 0.25, 0.125, 0.0625, and 0.03125 ml of HSEs were used to challenge to HeLa cells to obtain a standard curve of 
L1 protein level and infec+vity. (B) Protein levels of HPV16‐L1, FLAG‐ A3 proteins, and GAPDH in 2 ml (2% of a 6‐well plate) of each HSE were determined by 
immunoblomng followed by densitometry. For control cells transfected with pFLAG‐ GFP, L1 protein levels in 2.0, 1.0, 0.5, and 0.25 ml of HSEs were 
determined. (C) Each HSE was plosed according to its L1 protein level and luciferase ac+vity. Serially diluted HSEs from GFP transfected cells were plosed to 
compare infec+vity of HSEs containing diﬀerent amounts of L1. Errors bars in (A) and (C) represent the standard devia+ons of three independent experiments. 
Fig. 2, top). Meanwhile, Myc‐L1 was not obviously decreased by Fig. 2. A3A expression, but not that of other A3s, decreased the amount of encapsi‐ dated 
DNA. (A, B) Total DNA from 293FT cells (A) or corresponding HSEs (B) were subjected to qPCR to measure copy numbers of the reporter plasmid (pEF‐nLuc). 
Re‐ porter plasmid levels in HSEs were equivalent to encapsidated reporter plasmid levels, as HSEs were prepared aaer DNaseI treatment. Reporter plasmid 
levels from 0.167 ml of each HSE were determined. For the GFP control, reporter plasmid levels from 0.167 ml of the HSE and its serial dilu+on were 
determined. N.S. ¼ not sta+s+cally signi ﬁcant. (C) HSEs from each transfected cell were plosed according to L1 protein level and copy number of reporter 
plasmid. Serially diluted HSEs from GFP transfected cells were plosed to compare the copy numbers between HSEs containing diﬀerent amount of L1. Errors 
bars represent standard devia+ons of two independent experiments.  
Fig. 3. Physical interac+on of A3 proteins with HPV16 L1. 293FT cells were transfected with FLAG‐
tagged A3 proteins and Myc‐tagged L1 and immunoprecipitated by an+‐ FLAG or an+‐Myc 
an+body. Immunoprecipitated samples as well as the input were immunoblosed by an+‐FLAG 
and an+‐Myc an+bodies. GAPDH blot was used as a control. Displayed is representa+ve of two 
independent experiments.  
